OLODATEROL Respimat
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparison table: Inhaled drugs for treatment of COPD.
Journal: The Medical letter on drugs and therapeutics
Published: August 26, 2024
Expanded table: Correct use of inhalers for asthma.
Journal: The Medical letter on drugs and therapeutics
Published: January 15, 2021
Table: Correct Use of inhalers for COPD.
Journal: The Medical letter on drugs and therapeutics
Published: September 22, 2020
Comparison table: Inhaled long-acting bronchodilators for treatment of COPD.
Journal: The Medical letter on drugs and therapeutics
Published: September 22, 2020
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.
Journal: Therapeutic advances in respiratory disease
Published: July 14, 2016
Olodaterol for the treatment of chronic obstructive pulmonary disease.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: June 30, 2016
Olodaterol (Striverdi Respimat). COPD: just another beta-2 agonist.
Journal: Prescrire international
Published: May 18, 2016
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol.
Journal: Therapeutics and clinical risk management
Published: December 18, 2015
Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
Journal: Expert review of clinical pharmacology
Published: August 22, 2015
Olodaterol: a review of its use in chronic obstructive pulmonary disease.
Journal: Drugs
Published: March 17, 2015
Last Updated: 02/24/2026